Angiotensin II induces superoxide anion production by mesangial cells

E. A. Jaimes, J. M. Galceran, Leopoldo Raij

Research output: Contribution to journalArticle

236 Citations (Scopus)

Abstract

Background. The recognized role of angiotensin II (Ang II) in the pathogenesis of the progression of renal disease cannot be solely attributed to Ang II's hemodynamic effects. Indeed, growth stimulating signals driven by Ang II promote mesangial cell (MC) hypertrophy and extracellular matrix production, prominent features of progressive glomerular injury. Superoxide anion (O2-) avidly interacts with nitric oxide, an endogenous vasodilator that inhibits growth factor stimulated MC growth and matrix production. In addition, O2- acting as an intracellular signal is linked to growth related responses such as activation of mitogen activated protein (MAP) kinases. The studies reported herein were designed to investigate: (a) whether Ang II induces MC O2- production and (b) if increased O2- production elicits growth responses in MC. Methods. MC were exposed to Ang II for 24 or 48 hours. In some experiments, in addition to Ang II, MC were exposed to: diphenylenieodonium (DPI), an inhibitor of the flavin containing NADH/NADPH oxidase; losartan (LOS), an Ang II type 1 (AT1) receptor blocker; PD 98059, a MAP kinases inhibitor; the protein kinase C inhibitors Calphostin C or H-7; and the tyrosine kinase inhibitors, herbymycin A or genistein. Results. Ang II (10-5 M to 10-8 M) dose dependently increased MC O2- production up to 125% above control (ED 50 5 x 10-7 M). LOS as well as DPI, and the PKC inhibitors blocked Ang II stimulated MC O2- production. Ang II dose dependently increased MC 3H-leucine incorporation, and MC protein content, two markers of MC hypertrophy, as well as 3H-thymidine incorporation, a marker of MC hyperplasia. PD98059, a specific inhibitor of MAP kinases prevented Ang II induced MC hypertrophy. Moreover, LOS, DPI, and the PKC inhibitors each independently inhibited MC 3H-leucine incorporation, thereby establishing the specificity of Ang II induced O2- in driving MC hypertrophy. Conclusions. The current studies demonstrate a previously unrecognized link between Ang II and MC O2- production that may participate in the pathophysiology of progressive renal disease by concomitantly affecting the hemodynamics of the glomerular microcirculation as well as growth related responses of MC to injury.

Original languageEnglish
Pages (from-to)775-784
Number of pages10
JournalKidney International
Volume54
Issue number3
DOIs
StatePublished - Sep 7 1998
Externally publishedYes

Fingerprint

Mesangial Cells
Superoxides
Angiotensin II
Hypertrophy
Losartan
Mitogen-Activated Protein Kinases
Growth
Protein Kinase Inhibitors
Leucine
Hemodynamics
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Angiotensin II Type 1 Receptor Blockers
Kidney
Protein C Inhibitor
Genistein
NADPH Oxidase
Wounds and Injuries
Microcirculation

Keywords

  • Angiotensin II
  • Hyperplasia
  • Hypertrophy
  • Mesangium
  • NADPH oxidase
  • Nitric oxide
  • Superoxide

ASJC Scopus subject areas

  • Nephrology

Cite this

Angiotensin II induces superoxide anion production by mesangial cells. / Jaimes, E. A.; Galceran, J. M.; Raij, Leopoldo.

In: Kidney International, Vol. 54, No. 3, 07.09.1998, p. 775-784.

Research output: Contribution to journalArticle

Jaimes, E. A. ; Galceran, J. M. ; Raij, Leopoldo. / Angiotensin II induces superoxide anion production by mesangial cells. In: Kidney International. 1998 ; Vol. 54, No. 3. pp. 775-784.
@article{af5bb3331608402bb6e1cdbc89c443a4,
title = "Angiotensin II induces superoxide anion production by mesangial cells",
abstract = "Background. The recognized role of angiotensin II (Ang II) in the pathogenesis of the progression of renal disease cannot be solely attributed to Ang II's hemodynamic effects. Indeed, growth stimulating signals driven by Ang II promote mesangial cell (MC) hypertrophy and extracellular matrix production, prominent features of progressive glomerular injury. Superoxide anion (O2-) avidly interacts with nitric oxide, an endogenous vasodilator that inhibits growth factor stimulated MC growth and matrix production. In addition, O2- acting as an intracellular signal is linked to growth related responses such as activation of mitogen activated protein (MAP) kinases. The studies reported herein were designed to investigate: (a) whether Ang II induces MC O2- production and (b) if increased O2- production elicits growth responses in MC. Methods. MC were exposed to Ang II for 24 or 48 hours. In some experiments, in addition to Ang II, MC were exposed to: diphenylenieodonium (DPI), an inhibitor of the flavin containing NADH/NADPH oxidase; losartan (LOS), an Ang II type 1 (AT1) receptor blocker; PD 98059, a MAP kinases inhibitor; the protein kinase C inhibitors Calphostin C or H-7; and the tyrosine kinase inhibitors, herbymycin A or genistein. Results. Ang II (10-5 M to 10-8 M) dose dependently increased MC O2- production up to 125{\%} above control (ED 50 5 x 10-7 M). LOS as well as DPI, and the PKC inhibitors blocked Ang II stimulated MC O2- production. Ang II dose dependently increased MC 3H-leucine incorporation, and MC protein content, two markers of MC hypertrophy, as well as 3H-thymidine incorporation, a marker of MC hyperplasia. PD98059, a specific inhibitor of MAP kinases prevented Ang II induced MC hypertrophy. Moreover, LOS, DPI, and the PKC inhibitors each independently inhibited MC 3H-leucine incorporation, thereby establishing the specificity of Ang II induced O2- in driving MC hypertrophy. Conclusions. The current studies demonstrate a previously unrecognized link between Ang II and MC O2- production that may participate in the pathophysiology of progressive renal disease by concomitantly affecting the hemodynamics of the glomerular microcirculation as well as growth related responses of MC to injury.",
keywords = "Angiotensin II, Hyperplasia, Hypertrophy, Mesangium, NADPH oxidase, Nitric oxide, Superoxide",
author = "Jaimes, {E. A.} and Galceran, {J. M.} and Leopoldo Raij",
year = "1998",
month = "9",
day = "7",
doi = "10.1046/j.1523-1755.1998.00068.x",
language = "English",
volume = "54",
pages = "775--784",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Angiotensin II induces superoxide anion production by mesangial cells

AU - Jaimes, E. A.

AU - Galceran, J. M.

AU - Raij, Leopoldo

PY - 1998/9/7

Y1 - 1998/9/7

N2 - Background. The recognized role of angiotensin II (Ang II) in the pathogenesis of the progression of renal disease cannot be solely attributed to Ang II's hemodynamic effects. Indeed, growth stimulating signals driven by Ang II promote mesangial cell (MC) hypertrophy and extracellular matrix production, prominent features of progressive glomerular injury. Superoxide anion (O2-) avidly interacts with nitric oxide, an endogenous vasodilator that inhibits growth factor stimulated MC growth and matrix production. In addition, O2- acting as an intracellular signal is linked to growth related responses such as activation of mitogen activated protein (MAP) kinases. The studies reported herein were designed to investigate: (a) whether Ang II induces MC O2- production and (b) if increased O2- production elicits growth responses in MC. Methods. MC were exposed to Ang II for 24 or 48 hours. In some experiments, in addition to Ang II, MC were exposed to: diphenylenieodonium (DPI), an inhibitor of the flavin containing NADH/NADPH oxidase; losartan (LOS), an Ang II type 1 (AT1) receptor blocker; PD 98059, a MAP kinases inhibitor; the protein kinase C inhibitors Calphostin C or H-7; and the tyrosine kinase inhibitors, herbymycin A or genistein. Results. Ang II (10-5 M to 10-8 M) dose dependently increased MC O2- production up to 125% above control (ED 50 5 x 10-7 M). LOS as well as DPI, and the PKC inhibitors blocked Ang II stimulated MC O2- production. Ang II dose dependently increased MC 3H-leucine incorporation, and MC protein content, two markers of MC hypertrophy, as well as 3H-thymidine incorporation, a marker of MC hyperplasia. PD98059, a specific inhibitor of MAP kinases prevented Ang II induced MC hypertrophy. Moreover, LOS, DPI, and the PKC inhibitors each independently inhibited MC 3H-leucine incorporation, thereby establishing the specificity of Ang II induced O2- in driving MC hypertrophy. Conclusions. The current studies demonstrate a previously unrecognized link between Ang II and MC O2- production that may participate in the pathophysiology of progressive renal disease by concomitantly affecting the hemodynamics of the glomerular microcirculation as well as growth related responses of MC to injury.

AB - Background. The recognized role of angiotensin II (Ang II) in the pathogenesis of the progression of renal disease cannot be solely attributed to Ang II's hemodynamic effects. Indeed, growth stimulating signals driven by Ang II promote mesangial cell (MC) hypertrophy and extracellular matrix production, prominent features of progressive glomerular injury. Superoxide anion (O2-) avidly interacts with nitric oxide, an endogenous vasodilator that inhibits growth factor stimulated MC growth and matrix production. In addition, O2- acting as an intracellular signal is linked to growth related responses such as activation of mitogen activated protein (MAP) kinases. The studies reported herein were designed to investigate: (a) whether Ang II induces MC O2- production and (b) if increased O2- production elicits growth responses in MC. Methods. MC were exposed to Ang II for 24 or 48 hours. In some experiments, in addition to Ang II, MC were exposed to: diphenylenieodonium (DPI), an inhibitor of the flavin containing NADH/NADPH oxidase; losartan (LOS), an Ang II type 1 (AT1) receptor blocker; PD 98059, a MAP kinases inhibitor; the protein kinase C inhibitors Calphostin C or H-7; and the tyrosine kinase inhibitors, herbymycin A or genistein. Results. Ang II (10-5 M to 10-8 M) dose dependently increased MC O2- production up to 125% above control (ED 50 5 x 10-7 M). LOS as well as DPI, and the PKC inhibitors blocked Ang II stimulated MC O2- production. Ang II dose dependently increased MC 3H-leucine incorporation, and MC protein content, two markers of MC hypertrophy, as well as 3H-thymidine incorporation, a marker of MC hyperplasia. PD98059, a specific inhibitor of MAP kinases prevented Ang II induced MC hypertrophy. Moreover, LOS, DPI, and the PKC inhibitors each independently inhibited MC 3H-leucine incorporation, thereby establishing the specificity of Ang II induced O2- in driving MC hypertrophy. Conclusions. The current studies demonstrate a previously unrecognized link between Ang II and MC O2- production that may participate in the pathophysiology of progressive renal disease by concomitantly affecting the hemodynamics of the glomerular microcirculation as well as growth related responses of MC to injury.

KW - Angiotensin II

KW - Hyperplasia

KW - Hypertrophy

KW - Mesangium

KW - NADPH oxidase

KW - Nitric oxide

KW - Superoxide

UR - http://www.scopus.com/inward/record.url?scp=0031708389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031708389&partnerID=8YFLogxK

U2 - 10.1046/j.1523-1755.1998.00068.x

DO - 10.1046/j.1523-1755.1998.00068.x

M3 - Article

C2 - 9734602

AN - SCOPUS:0031708389

VL - 54

SP - 775

EP - 784

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 3

ER -